A kind of engineering bacillus amyloliquefaciens bacteria producing Fengyuansu and its construction method and application

By overexpressing the SigmaH gene in Bacillus amyloliquefaciens TF28 and constructing the recombinant vector pHT43-sigmaH, the problem of low synthesis efficiency of nutrient was solved, and high-yield fermentation production of nutrient was achieved.

CN116837003BActive Publication Date: 2024-11-01INST OF MICROBIOLOGY HEILONGJIANG ACADEMY OF SCI
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202210288093.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-03-23
Publication Date
2024-11-01
Estimated Expiration
2042-03-23

AI Technical Summary

Technical Problem

Existing technologies have low efficiency in the synthesis of nutrient-rich elements, high difficulty in constructing engineered strains, large sequence length of synthesized gene clusters, making direct gene editing difficult, and the synthesis of nutrient-rich elements is limited by various culture conditions.

Method used

Overexpression of the SigmaH gene in Bacillus amyloliquefaciens TF28 and subsequent electroporation of the recombinant vector pHT43-sigmaH enhanced the synthesis of nutrient.

Benefits of technology

High-yield synthesis of nutrient was achieved, with improved conversion efficiency. After 48 hours of fermentation, the yield was 8.01 times higher than that of the original strain, reaching 596.32 mg/L.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116837003B_ABST
    Figure CN116837003B_ABST
Patent Text Reader

Abstract

A Bacillus amyloliquefaciens engineered bacterium for producing Fengyuansu and a construction method and application thereof belong to the field of genetic engineering technology. In order to solve the technical problems existing in the synthesis of Fengyuansu in the prior art, the present invention overexpresses the SigmaH gene in Bacillus amyloliquefaciens TF28, obtains a recombinant vector, and then uses an electro-transformation method to obtain the Bacillus amyloliquefaciens engineered bacterium. The efficiency of obtaining expression-positive bacterial transformants using the construction method of the Bacillus amyloliquefaciens engineered bacterium of the present invention is improved, and the transformation efficiency can reach 3.8×10 6 cfu / μg DNA; and fermentation with the engineered Bacillus amyloliquefaciens can achieve a high yield of fengyuan at 48h of fermentation. The yield of the positive clone after 48h of fermentation is increased by 8.01 times compared with the original TF28 strain, and the yield increases from 74.41mg / L to 596.32mg / L.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an engineering bacillus amyloliquefaciens for producing fengyuanin and a construction method and application thereof, belonging to the technical field of genetic engineering. Background Art

[0002] Fengycin is a lipopeptide antibiotic with strong antifungal activity and a broad antibacterial spectrum. It also has anti-tumor, anti-viral, anti-infective and other biological effects. It has stable physical and chemical properties and good heat resistance, and is expected to play an important role in plant protection, tumor prevention and treatment and other fields. Fengycin is mainly synthesized through the non-ribosomal synthesis pathway of Bacillus, but the efficiency of synthesizing fengycin in natural strains is relatively low due to many factors. It is expected to improve the synthesis level of fengycin and realize industrial application by modifying Bacillus, but the construction of fengycin engineering strains is difficult, the length of the synthetic gene cluster sequence is large, and it is difficult to directly perform gene editing operations; and the synthesis efficiency of fengycin in different strains is limited by many culture conditions. Therefore, it is urgent to construct a high-yield fengycin Bacillus amyloliquefaciens engineering bacteria and find a corresponding fermentation method. Summary of the invention

[0003] In order to solve the technical problems existing in the synthesis of Fengyuan in the prior art, the present invention provides an engineered Bacillus amyloliquefaciens for producing Fengyuan, wherein the engineered Bacillus amyloliquefaciens is a Bacillus amyloliquefaciens TF28 overexpressing the SigmaH gene, and the nucleotide sequence of the SigmaH gene is shown in SEQ ID NO.1.

[0004] The present invention also provides a method for constructing the above-mentioned Bacillus amyloliquefaciens engineered bacteria, which specifically comprises the following steps:

[0005] (1) Cloning and synthesis of sigmaH gene: Using the genome of Bacillus amyloliquefaciens TF28 as a template, sigmaH gene was amplified by PCR using primer pairs, and gel recovery, ligation, transformation and identification were performed;

[0006] (2) Recombinant vector construction and transformation: Using the Bacillus expression vector pHT43 as the backbone, the recombinant expression vector pHT43-sigmaH was constructed, positive clones were obtained by transformation, and plasmids were extracted by shaking;

[0007] (3) Preparation of electroporated cells: Precool the TF28 bacterial solution, centrifuge, collect the cells, wash them in electroporated cell buffer, centrifuge, dissolve the cells in electroporated cell buffer, and store them at -80°C;

[0008] (4) Electrotransformation of the recombinant vector: The pre-cooled mixture of the plasmid obtained in step (2) and the electrotransformed cells of the TF28 strain is electrotransformed using an electrotransformation instrument, and the engineered Bacillus amyloliquefaciens is obtained after culture and identification.

[0009] It is further defined that step (2) is to use the connection product pMD18t-sigmaH of step (1) as a template, use PCR amplification to add two restriction sites, BamHI and XbaI, obtain the target fragment, connect it to the pMD18-T vector, transform to obtain the positive clone, extract the plasmid after shaking, and perform double restriction digestion simultaneously with the pHT43 backbone vector, respectively recover the pHT43 linearized vector and the sigmaH restriction product, and obtain the plasmid after connection, transformation, shaking, and extraction.

[0010] It is further defined that the composition of the electroporation cell buffer in step (3) is, by mass fraction, 8.5% sorbitol, 8.5% mannitol, 10% glycerol, and the remainder is water.

[0011] Further, step (3) is to inoculate the TF28 strain into NYD liquid medium and culture until OD 600 The concentration of the bacterial cell was 0.8-1.0, and the bacterial solution was placed in ice for 30-60 minutes. The bacterial cells were obtained after centrifugation, washed with electroporation cell buffer and centrifuged. The bacterial cells were dissolved with pre-cooled electroporation cell buffer to a final concentration of 10 9 ~2×10 10 CFU / mL, stored at -80℃.

[0012] It is further defined that the electroconversion parameters in step (4) are voltage 2000 V, capacitance 25 μF, and pulse resistance 100 Ω.

[0013] It is further defined that step (4) is to take a total amount of 80-150 ng of the plasmid obtained in step (2) and mix it with TF28 electrotransformed cells, transfer the mixture to a pre-cooled electrotransformation cup, place it in the sample slot of the electrotransformer for transformation, release the electric pulse, take out the electrotransformation cup, and immediately add 1 mL of NYD antibiotic-free culture medium. After cultivation, extract the plasmid and perform enzyme digestion identification. The strain that is successfully digested is the engineered Bacillus amyloliquefaciens.

[0014] The present invention also provides the use of the Bacillus amyloliquefaciens engineering bacteria in producing Fengyuansu.

[0015] It is further defined that the application is to inoculate the engineered bacteria of Bacillus amyloliquefaciens into an antimicrobial lipopeptide optimized culture medium for fermentation; the composition of the antimicrobial lipopeptide optimized culture medium is: in mass fraction, 21‰ yeast extract, 21‰ beef extract, 21‰ ammonium sulfate, 2.21‰ magnesium sulfate, 0.1‰ calcium chloride, 0.1‰ manganese sulfate, 1.5‰ potassium dihydrogen phosphate, 3‰ dipotassium hydrogen phosphate, 2.0% fructose, 4% glucose, and the balance is water, and the pH is adjusted to 7.5.

[0016] It is further defined that the fermentation is cultured at 28-30°C and 140-200 rpm for 36-48 hours.

[0017] Beneficial effects of the present invention:

[0018] The efficiency of obtaining expression-positive bacterial transformants by constructing the Bacillus amyloliquefaciens engineered bacteria of the present invention is improved, and the transformation efficiency can reach 3.8×10 6 cfu / μg DNA; and using the engineered Bacillus amyloliquefaciens for fermentation, the effect of high yield of fengyuan can be achieved at 48h of fermentation. The yield of the positive clone after 48h of fermentation is increased by 8.01 times compared with the original TF28 strain, from 74.41mg / L to 596.32mg / L. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 This is the result of liquid chromatography analysis of synthetic Fengyuansu; Figure 1 A in the figure is the result of liquid chromatography analysis of synthetic Fengyuansu of the original strain TF28; Figure 1 B in the figure is a liquid chromatography analysis result diagram of the synthetic Fengyuansu produced by the Bacillus amyloliquefaciens engineered bacteria obtained in the present invention. DETAILED DESCRIPTION

[0020] The present invention is further described below in conjunction with specific embodiments and drawings, but the present invention is not limited to the embodiments.

[0021] The method is implemented based on Bacillus amyloliquefaciens strain TF28 (deposit number is CGMCC No.4038).

[0022] Example 1: Construction of an engineered bacillus amyloliquefaciens strain producing Fengyuansu

[0023] 1. Cloning and synthesis of sigmaH gene

[0024] The genome of strain TF28 was extracted using a bacterial genomic DNA extraction kit (TIANGEN, China). The TF28 genome was used as a template to perform PCR amplification to obtain the sigmaH gene. The primer sequences were:

[0025] sigmaH-F(SEQ ID NO.2):GTGAATCTACAGAACAGCAAGGG

[0026] sigmaH-R(SEQ ID NO.3):CTACAGGCTGATCTCTCTTATTTCTAAATAC

[0027] The PCR system is:

[0028]

[0029] The PCR program is:

[0030] Pre-denaturation: 98℃~30s

[0031] {Denaturation: 98℃-10s, annealing: 52℃-30s, extension: 72℃-45s} 30 cycles

[0032] Final extension: 72℃-2min

[0033] The target fragment was recovered by gel (Agarose Gel DNA Recovery Kit (Enhanced), TIANGEN) and ligated to the pMD18-T vector (pMD TM 18-T Vector Cloning Kit, TAKARA), incubated at 37°C for 30 min. The ligation product was transformed into Escherichia coli DH5a (DH5a competent cells, TIANGEN) and sequenced. The nucleotide sequence of sigmaH is shown in SEQ ID NO.1:

[0034] GTGAATCTACAGAACAGCAAGGGAAAGTTCAACAAAGTGCAATTTTGCCAGTTGGAGGACGAGCAGGTCATTGAAAAGGTTCATGTTGGGGATAGTGATGCGTTAGATTACTTGATTACGAAGTACCGTAATTTTGTACGGGCGAAAGCAAGGTCTTATTTTTT AATAGGGGCCGACAGAGAAGATATTGTACAGGAAGGGATGATAGGCTTATATAAGTCTATCCGAGACTTTAGAGAGGACAAGCTTACTTCATTTAAAGCTTTTGCAGAATTATGCATTACCCGCCAGATTATTACCGCAATAAAGACAGCTACCCGTCAGAAAC ACATTCCTTAAATTCCTATGTTTCTTTAGACAAACCTATTTTTGATGAAGAATCTGACAGAACACTGCTTGATGTCATTTCAGGCGCCAAAACGTTAAATCCTGAAGAGATGATTATTAATCAGGAAGAATTTGATGATATCGAAATGAAAATGGGAGAACTG CTGAGCGATCTGGAGAGAAAGGTGCTTGTTTTGTACTTGGACGGAAGAAGTTACCAAGAGATTTCAGATGACTTAAACCGACACGTAAAATCAGTCGATAATGCCCTGCAGCGCGTGAAGCGCAAGCTTGAAAAGTATTTAGAAATAAGAGAGATCAGCCTGTAG

[0035] 2. Recombinant vector construction and transformation

[0036] Using the Bacillus expression vector pHT43 as the backbone, the recombinant expression vector pHT43-sigmaH was constructed. The specific steps are as follows:

[0037] Using the pMD18t-sigmaH obtained above as a template, add a restriction site BamHI to the 5' primer end and a restriction site XbaI to the 3' primer end. The primer sequences are as follows:

[0038] sigmaH-BamHI-F(SEQ ID NO.4):CGCGGATCCGTGAATCTACAGAACAGCAAGGG

[0039] sigmaH-XbaI-R (SEQ ID NO.5): GCTCTAGACTACAGGCTGATCTCTCTTATTTCTAAATAC

[0040] The target fragment was obtained by PCR amplification, connected to the pMD18-T vector, and transformed into E. coli DH5α competent cells. Positive clones were selected and the plasmid was extracted after shaking with LB medium containing 50 μg / mL. Except for the plasmid extraction method, the above experimental method is consistent with the experimental method in step 1. The plasmid extraction method refers to the plasmid mini-extraction kit (China, TIANGEN).

[0041] The extracted plasmid was tested for concentration using Nanodrop and double-digested with the pHT43 backbone vector. The digestion system was as follows:

[0042] pHT43 backbone vector / pMD18t-sigmaH: 1 μg

[0043] BamHI (NEB, China): 1 μL

[0044] XbaI (NEB, China): 1 μL

[0045] Cut Smart Buffer (NEB, China): 5 μL

[0046] ddH2O: up to 50μL

[0047] The enzyme digestion was carried out at 37°C overnight and terminated in a water bath at 65°C. The pHT43 linearized vector and sigmaH digestion product were recovered separately.

[0048] The ligation reaction system is as follows:

[0049] 10x T4 Ligase Buffer (NEB, China): 2 μL

[0050] Vector DNA (pHT43 linearized vector): 37.5ng

[0051] Insert DNA (sigmaH): 50ng

[0052] T4 DNAligase (China, NEB): 1μL

[0053] ddH2O: up to 20μL

[0054] Ligation was carried out at 16°C overnight.

[0055] The ligation product was transformed into competent E. coli JM110 cells (TIANGEN, China) to demethylate the plasmid. After bacterial culture, the plate was coated with LB plates containing 50 ng / μL Amp. After overnight culture at 37°C, positive single clones were picked and inoculated into LB liquid medium with a concentration of 50 ng / μL Amp. The cells were cultured at 37°C for 12 h, the plasmid was extracted, and enzyme digestion was performed for identification. The successfully identified recombinant vectors could be used for the next transformation operation.

[0056] 3. Preparation of TF28 electroporated cells:

[0057] ① Prepare electroporation cell buffer, the ingredients are: by mass fraction, 8.5% sorbitol, 8.5% mannitol, 10% glycerol, dissolved in deionized water.

[0058] ② The TF28 strain was inoculated into NYD liquid medium (by mass fraction, beef extract 0.8%, yeast extract 5%, glucose 0.1%, pH 7.2-7.5), and cultured at 30℃ for 14h. At this time, OD 600 The concentration of the bacterial solution was 0.8-1.0, and the bacterial solution was placed in ice for 30 minutes.

[0059] ③ Centrifuge the bacterial solution at 4000rpm for 2min, collect the bacteria, and repeat once.

[0060] ④ Wash the centrifuged bacteria with pre-cooled electroporation cell buffer, centrifuge at 4000rpm for 2min, and discard the supernatant.

[0061] ⑤Repeat step ④ twice.

[0062] ⑥ Use an appropriate amount of pre-cooled electroporation cell buffer to dissolve the cells. The final concentration of the cells should be 10 9 ~2×10 10 CFU / mL.

[0063] ⑦ Dispense the bacterial solution into 1.5 mL Eppendorf tubes and store at -80°C. It is recommended to prepare and use immediately.

[0064] 4. Electrotransformation of recombinant vector:

[0065] The electroporation instrument used in this method is the Scientz-2C gene transfer instrument. The specific method is as follows:

[0066] ① Set the electroconversion parameters to voltage 2000V, capacitance 25μF, and pulse resistance 100Ω.

[0067] ② Take about 80 ng of the plasmid solution obtained in step 2 and mix it with the TF28 electroporated cells, and transfer the mixture to a pre-cooled 0.2 cm electroporation cup (Bio-rad, USA). Wipe off the ice water outside the electroporation cup and place it in the sample tank.

[0068] ③ Release the electric pulse, remove the electroporation cup, and immediately add 1 mL of NYD antibiotic-free culture medium.

[0069] ④ Carefully transfer the bacterial solution to a sterile 1.5 mL Eppendorf tube using a pipette and culture at 30°C, 100 rpm, with slow shaking for 2 h.

[0070] ⑤ After the culture is completed, take the culture medium of the transformed cells and spread it on the NYD plate containing 50 ng / μL of Amp, and culture until a single colony appears on the plate.

[0071] ⑥ Pick a single colony and inoculate it into NYD liquid culture medium containing 50 μg / mL Amp, culture it at 30°C, 140 rpm with constant temperature shaking for 14 hours, extract the plasmid, and perform enzyme digestion identification. The strain that successfully digests the bacteria is the engineered Bacillus amyloliquefaciens.

[0072] Example 2: Application of engineered Bacillus amyloliquefaciens in the production of Fengyuansu

[0073] 1. Fermentation of engineered Bacillus amyloliquefaciens

[0074] The engineered Bacillus amyloliquefaciens was inoculated into the antimicrobial lipopeptide optimized medium (OML) at an inoculation rate of 2%, and the culture was carried out in a constant temperature shaking flask at 30° C. and 180 rpm for 48 hours to obtain a fermentation liquid.

[0075] The composition of the antimicrobial lipopeptide optimized medium (OML) is as follows: by mass fraction, 21‰ yeast extract, 21‰ beef extract, 21‰ ammonium sulfate, 2.21‰ magnesium sulfate, 0.1‰ calcium chloride, 0.1‰ manganese sulfate, 1.5‰ potassium dihydrogen phosphate, 3‰ dipotassium hydrogen phosphate, 2.0% fructose, 4% glucose, and the balance is water, and the pH is adjusted to 7.5.

[0076] 2. Separation and purification of Fengyuansu

[0077] ① Centrifuge the fermentation broth obtained in step 1 (10000 rpm, 5 min), take the supernatant, add 5 mol / L HCl to the supernatant to pH 2.0, and let it stand at 4°C for 12 h.

[0078] ② Centrifuge at 10000rpm for 5min, take the precipitate and dry it naturally. Add 5mL methanol to the dried precipitate to dissolve it, filter the solvent through a sterile 0.22μm nylon filter membrane, transfer it to a 1.5mL Eppendorf tube, and store it at 4℃.

[0079] ③Liquid chromatography analysis: The antimicrobial lipopeptide fenmucin was separated and purified using a C18 reverse phase column. Water / TFA was used as mobile phase A, methanol / TFA was used as mobile phase B, and the concentration of mobile phase B was increased from 30% to 70% within 10 minutes, and then finally increased to 100% within 25 minutes for separation and purification. The detection wavelength was 210nm. The fenmucin standard (MCE, USA) was used to quantify the fenmucin fermentation level of Bacillus amyloliquefaciens engineered bacteria.

[0080] The original TF28 strain was used for fermentation and separation and purification, and the fermentation level of Fengyuansu was quantified. The fermentation conditions and separation and purification conditions were the same as those of the engineered bacteria.

[0081] The results are as follows Figure 1 As shown in Figure 2, after electroporation, the transformation efficiency of the obtained TF28 positive clones can reach 3.8×10 6 CFU / μgDNA. The yield of the positive clones after 48h of fermentation increased by 8.01 times compared with the original TF28 strain, from 74.41mg / L to 596.32mg / L.

[0082] Although the present invention has been disclosed as above in the form of preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims. SEQUENCE LISTING <110> Institute of Microbiology, Heilongjiang Academy of Sciences <120> A kind of engineering bacillus amyloliquefaciens bacteria producing Fengyuansu and its construction method and application <160> 5 <170> PatentIn version 3.5 <210> 1 <211> 657 <212> DNA <213> Bacillus amyloliquefaciens <400> 1 gtgaatctac agaacagcaa gggaaagttc aacaaagtgc aattttgcca gttggaggac 60 gagcaggtca ttgaaaaggt tcatgttggg gatagtgatg cgttagatta cttgattacg 120 aagtaccgta attttgtacg ggcgaaagca aggtcttatt ttttaatagg ggccgacaga 180 gaagatattg tacaggaagg gatgataggc ttatataagt ctatccgaga ctttagagag 240 gacaagctta cttcatttaa agcttttgca gaattatgca ttacccgcca gattattacc 300 gcaataaaga cagctacccg tcagaaacac attcctttaa attcctatgt ttctttagac 360 aaacctattt ttgatgaaga atctgacaga acactgcttg atgtcatttc aggcgccaaa 420 acgttaaatc ctgaagagat gattattaat caggaagaat ttgatgatat cgaaatgaaa 480 atgggagaac tgctgagcga tctggagaga aaggtgcttg ttttgtactt ggacggaaga 540 agttaccaag agatttcaga tgacttaaac cgacacgtaa aatcagtcga taatgccctg 600 cagcgcgtga agcgcaagct tgaaaagtat ttagaaataa gagagatcag cctgtag 657 <210> 2 <211> 23 <212> DNA <213> Synthetic <400> 2 gtgaatctac agaacagcaa ggg 23 <210> 3 <211> 31 <212> DNA <213> Synthetic <400> 3 ctacaggctg atctctctta tttctaaata c 31 <210> 4 <211> 32 <212> DNA <213> Synthesis <400> 4 cgcggatccg tgaatctaca gaacagcaag gg 32 <210> 5 <211> 39 <212> DNA <213> Synthesis <400> 5 gctctagact acaggctgat ctctcttatt tctaaatac 39

Claims

1. An engineered bacillus amyloliquefaciens strain for producing Fengyuansu, characterized in that: The Bacillus amyloliquefaciens engineered bacteria is a Bacillus amyloliquefaciens ) TF28 overexpresses the SigmaH gene, the nucleotide sequence of the SigmaH gene is shown in SEQ ID NO.1; the deposit number of the Bacillus amyloliquefaciens TF28 is CGMCC No.4038.

2. The method for constructing the Bacillus amyloliquefaciens engineered bacteria according to claim 1, characterized in that: The specific steps include: (1) Cloning and synthesis of sigmaH gene: Using the genome of Bacillus amyloliquefaciens TF28 as a template, sigmaH gene was amplified by PCR using primer pairs, and gel recovery, ligation, transformation and identification were performed; (2) Recombinant vector construction and transformation: Using the Bacillus expression vector pHT43 as the backbone, the recombinant expression vector pHT43-sigmaH was constructed, positive clones were obtained by transformation, and plasmids were extracted by shaking; (3) Preparation of electroporated cells: precooling and centrifuging the TF28 bacterial solution, collecting the cells, washing them in an electroporated cell buffer, centrifuging them, dissolving the cells in an electroporated cell buffer, and storing them at -80°C; the electroporated cell buffer comprises, by mass, 8.5% sorbitol, 8.5% mannitol, 10% glycerol, and the remainder water; (4) Electrotransformation of the recombinant vector: The pre-cooled mixture of the plasmid obtained in step (2) and the electrotransformed cells of the TF28 strain is electrotransformed using an electrotransformation instrument, and the engineered Bacillus amyloliquefaciens is obtained after culture and identification.

3. The construction method according to claim 2, characterized in that: Step (2) is to use the ligation product pMD18t-sigmaH of step (1) as a template, to add two restriction sites, BamHI and XbaI, by PCR amplification, to obtain the target fragment, to ligate to the pMD18-T vector, to transform to obtain the positive clone, to extract the plasmid after shaking, to perform double restriction digestion simultaneously with the pHT43 backbone vector, to recover the pHT43 linearized vector and the sigmaH restriction product respectively, and to obtain the plasmid after connection, transformation, shaking and extraction.

4. The construction method according to claim 2, characterized in that: The composition of the electroporation cell buffer in step (3) is, by mass fraction, 8.5% sorbitol, 8.5% mannitol, 10% glycerol, and the remainder is water.

5. The construction method according to claim 4, characterized in that: Step (3) is to inoculate the TF28 strain into NYD liquid medium and culture until OD 600 The concentration of the bacterial cell was 0.8-1.0, and the bacterial solution was placed in ice for 30-60 minutes. The bacterial cells were obtained after centrifugation, washed with electroporation cell buffer and centrifuged. The bacterial cells were dissolved with pre-cooled electroporation cell buffer to a final concentration of 10 9 ~2×10 10 CFU / mL, stored at -80℃.

6. The construction method according to claim 2, characterized in that: The electroconversion parameters in step (4) are voltage 2000 V, capacitance 25 μF, and pulse resistance 100 Ω.

7. The construction method according to claim 2, characterized in that: Step (4) is to take a total of 80-150 ng of the plasmid obtained in step (2) and mix it with the TF28 electroporated cells, transfer the mixture to a pre-cooled electroporation cup, place it in the sample slot of the electroporation instrument for transformation, release the electric pulse, take out the electroporation cup, and immediately add 1 mL of NYD antibiotic-free culture medium. After culturing, extract the plasmid and perform enzyme digestion identification. The strain that is successfully digested is the engineered Bacillus amyloliquefaciens.

8. Use of the engineered bacillus amyloliquefaciens according to claim 1 in producing Fengyuansu.

9. The use according to claim 8, characterized in that: The application is to inoculate the engineered bacillus amyloliquefaciens into an antimicrobial lipopeptide optimized culture medium for fermentation; the composition of the antimicrobial lipopeptide optimized culture medium is: in terms of mass fraction, 21‰ yeast extract, 21‰ beef extract, 21‰ ammonium sulfate, 2.21‰ magnesium sulfate, 0.1‰ calcium chloride, 0.1‰ manganese sulfate, 1.5‰ potassium dihydrogen phosphate, 3‰ dipotassium hydrogen phosphate, 2.0% fructose, 4% glucose, and the balance is water, and the pH is adjusted to 7.

5.

10. The use according to claim 9, characterized in that: The fermentation is carried out by constant temperature shaking flask culture at 28°C-30°C and 140-200 rpm for 36-48 hours.

Citation Information

Cited By

  • Bacillus amyloliquefaciens for producing abinogen from corn steep liquor and application of bacillus amyloliquefaciens

    CN121991858A